BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32233022)

  • 1. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S
    J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
    PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.
    Li C; Yao W; Zhao C; Yang G; Wei J; Qi Y; Huang R; Zhao Q; Hao C
    Biomed Res Int; 2020; 2020():3075729. PubMed ID: 33381546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
    Peng Q; Li R; Li Y; Xu X; Ni W; Lin H; Ning L
    J Cell Mol Med; 2020 Nov; 24(22):13346-13355. PubMed ID: 33047898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.
    Xu N; Wu YP; Yin HB; Xue XY; Gou X
    J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.
    Wang JD; Zhou HS; Tu XX; He Y; Liu QF; Liu Q; Long ZJ
    Aging (Albany NY); 2019 May; 11(10):3333-3347. PubMed ID: 31164492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
    Xu Q; Yin H; Ao H; Leng X; Liu M; Liu Y; Ma J; Wang X
    J Cell Biochem; 2019 Oct; 120(10):18094-18103. PubMed ID: 31144382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explore prognostic biomarker of bladder cancer based on competing endogenous network.
    Li F; Guo H; Liu B; Liu N; Xu Z; Wang Y; Zhou H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
    Song W; Miao DL; Chen L
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
    Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
    Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.